Shilpa Medicare Share Price

  • 658.60-9.55 (-1.43%)
  • Volume: 1,79,183
  • Closed
  • Last Updated On: 12 Jul, 2024, 04:04 PM IST
Loading...

Shilpa Medicare Share P...

  • 658.60-9.55 (-1.43%)
  • Volume: 1,79,183
Advertisment

Shilpa Medicare share price insights

View All
  • Company has spent 7.97% of its operating revenues towards interest expenses and 24.44% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 21.06% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

  • Stock generated 21.06% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

  • Shilpa Medicare Ltd. share price moved down by -1.43% from its previous close of Rs 668.15. Shilpa Medicare Ltd. stock last traded price is 658.60

    Share PriceValue
    Today/Current/Last658.60
    Previous Day668.15666.30

InsightsShilpa Medicare

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    202.29
    EPS - TTM
    (₹)
    3.26
    MCap
    (₹ Cr.)
    6,440.51
    Sectoral MCap Rank
    43
    PB Ratio
    (x)
    3.63
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    1.00
    Beta

    Beta

    1 Month-0.14
    3 Months0.13
    6 Months0.39
    1 Year0.73
    3 Years0.90

    -0.14
    VWAP
    (₹)
    661.82
    52W H/L
    (₹)
    685.00 / 295.05

    Shilpa Medicare Share Price Returns

    1 Day-1.43%
    1 Week-0.24%
    1 Month22.47%
    3 Months30.22%
    1 Year118.26%
    3 Years9.26%
    5 Years89.28%

    ET Stock ScreenersTop Score Companies

    Check whether Shilpa Medicare belongs to analysts' top-rated companies list?

    View Stock Screeners

    Shilpa Medicare Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Shilpa Medicare Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Shilpa Medicare Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 7.97% of its operating revenues towards interest expenses and 24.44% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income294.19288.70314.79262.11265.73
      Total Income Growth (%)1.90-8.2920.10-1.370.19
      Total Expenses242.13247.25280.47239.00251.03
      Total Expenses Growth (%)-2.07-11.8517.35-4.79-1.67
      EBIT52.0641.4534.3223.1014.71
      EBIT Growth (%)25.5920.7948.5357.0947.86
      Profit after Tax (PAT)24.504.581.571.18-8.04
      PAT Growth (%)434.93190.8733.56--
      EBIT Margin (%)17.7014.3610.908.815.53
      Net Profit Margin (%)8.331.590.500.45-3.03
      Basic EPS (₹)2.820.530.190.14-0.93
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income110.7086.3197.38104.5286.83
      Total Income Growth (%)28.26-11.37-6.8420.3825.40
      Total Expenses96.5679.7980.2087.00107.21
      Total Expenses Growth (%)21.02-0.52-7.82-18.8544.57
      EBIT14.146.5217.1717.52-20.38
      EBIT Growth (%)116.96-62.06-1.99--
      Profit after Tax (PAT)9.742.706.607.90-28.93
      PAT Growth (%)261.06-59.15-16.42--
      EBIT Margin (%)12.777.5517.6416.76-23.47
      Net Profit Margin (%)8.803.126.787.56-33.31
      Basic EPS (₹)1.120.310.760.91-3.33
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue1,159.771,067.511,159.77931.27924.85
      Total Revenue Growth (%)8.64-7.9524.540.6923.79
      Total Expenses1,106.791,101.981,062.63795.32736.45
      Total Expenses Growth (%)0.443.7033.617.9918.15
      Profit after Tax (PAT)31.87-32.4860.66147.78156.15
      PAT Growth (%)--153.54-58.95-5.3639.10
      Operating Profit Margin (%)12.572.3012.0717.5121.25
      Net Profit Margin (%)2.76-3.095.2916.3917.19
      Basic EPS (₹)3.67-3.747.2618.1319.15
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue398.90316.35397.81289.30817.23
      Total Revenue Growth (%)26.10-20.4837.51-64.6020.29
      Total Expenses350.36359.08379.14252.03600.35
      Total Expenses Growth (%)-2.43-5.2950.43-58.0217.22
      Profit after Tax (PAT)26.9457.19140.99184.39193.72
      PAT Growth (%)-52.90-59.43-23.54-4.8156.09
      Operating Profit Margin (%)21.23-8.847.7616.8527.44
      Net Profit Margin (%)8.6923.0839.4971.7324.03
      Basic EPS (₹)3.106.5916.2422.6220.63

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets3,093.202,902.382,875.502,637.551,986.13
      Total Assets Growth (%)6.570.939.0232.8023.36
      Total Liabilities1,293.251,128.031,064.351,170.03664.68
      Total Liabilities Growth (%)14.655.98-9.0376.0358.23
      Total Equity1,799.961,774.361,811.151,467.501,321.45
      Total Equity Growth (%)1.44-2.0323.4211.0511.05
      Current Ratio (x)1.260.981.451.521.52
      Total Debt to Equity (x)0.520.450.370.490.25
      Contingent Liabilities0.00186.39103.8647.8550.99
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets2,418.592,517.362,896.122,517.392,021.28
      Total Assets Growth (%)-3.92-13.0815.0424.5421.16
      Total Liabilities275.87399.77830.45879.56567.86
      Total Liabilities Growth (%)-30.99-51.86-5.5854.8946.83
      Total Equity2,142.722,117.582,065.671,637.831,453.42
      Total Equity Growth (%)1.192.5126.1212.6913.41
      Current Ratio (x)1.672.631.941.652.52
      Total Debt to Equity (x)0.070.140.090.400.22
      Contingent Liabilities0.00510.05374.38207.7940.60

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 166.58 cr for investing activities which is an YoY decrease of 40.18%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities135.34226.17105.1347.07123.72
      Net Cash used in Investing Activities-166.58-278.48-285.50-404.28-288.85
      Net Cash flow from Financing Activities46.7845.8082.86436.37175.50
      Net Cash Flow11.35-6.51-97.5179.0310.20
      Closing Cash & Cash Equivalent30.2318.8325.34123.3444.56
      Closing Cash & Cash Equivalent Growth (%)60.56-25.71-79.46176.7829.69
      Total Debt/ CFO (x)6.913.526.4915.382.67
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities8.032.08173.8769.63129.79
      Net Cash used in Investing Activities155.82-94.80-378.97-238.13-295.08
      Net Cash flow from Financing Activities-163.0787.6897.23255.58170.10
      Net Cash Flow0.78-5.04-107.8887.08-2.58
      Closing Cash & Cash Equivalent2.922.107.13115.0128.19
      Closing Cash & Cash Equivalent Growth (%)38.97-70.58-93.80308.06-8.37
      Total Debt/ CFO (x)17.74138.111.129.382.47

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)1.76-1.823.329.9911.74
      Return on Capital Employed (%)6.031.146.107.7512.22
      Return on Assets (%)1.03-1.112.105.607.86
      Interest Coverage Ratio (x)2.752.045.307.2242.34
      Asset Turnover Ratio (x)0.380.360.1334.1645.71
      Price to Earnings (x)126.58-61.3557.1418.4212.77
      Price to Book (x)2.211.121.891.841.50
      EV/EBITDA (x)19.4023.0318.7315.639.59
      EBITDA Margin (%)21.9411.3919.0323.5026.07
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)1.252.706.8211.2513.32
      Return on Capital Employed (%)3.00-0.961.212.1213.31
      Return on Assets (%)1.112.274.867.329.58
      Interest Coverage Ratio (x)6.691.186.9110.8051.10
      Asset Turnover Ratio (x)0.130.090.130.1139.87
      Price to Earnings (x)149.2534.8424.5114.7710.30
      Price to Book (x)1.870.941.671.661.37
      EV/EBITDA (x)35.9192.2557.9649.678.92
      EBITDA Margin (%)37.259.9417.5225.5231.78

    Financial InsightsShilpa Medicare

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent 7.97% of its operating revenues towards interest expenses and 24.44% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 166.58 cr for investing activities which is an YoY decrease of 40.18%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Shilpa Medicare Peer Comparison

    • Shilpa Medicare Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 21.06% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 21.06% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 21.06% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 21.06% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Shilpa Medicare202.293.581.766.031.037.5112.573.183.671.260.526.91
      Marksans Pharma27.334.1115.1918.9711.7017.0419.9614.466.924.780.010.13
      Strides Shasun -119.204.06-3.3218.99-1.206.6313.872.00-7.761.031.143.44
      FDC Ltd26.213.8114.5418.5512.3612.5220.6015.7018.583.590.000.00
      Sun Pharma Adv Res.-19.7760.96-307.92-154.06-75.18-25.70-509.78-512.52-11.931.020.37-0.11
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Blue Jet Healthcare
      • Orchid Pharma
      • Aarti Pharmalabs
      • Aarti Drugs
      • Hikal Ltd

      Choose from Stocks

      Peers InsightsShilpa Medicare

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 21.06% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 21.06% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Shilpa Medicare Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Shilpa Medicare Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters44.3950.0150.0150.01
        Pledge90.4190.4190.4190.41
        FII9.085.638.528.60
        DII7.611.650.060.41
        Mutual Funds5.031.550.060.04
        Others38.9242.7141.4140.98
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters4,34,09,71544.39 %-5.61
        Pledge3,92,48,32490.41 %0.00
        FII88,80,2569.08 %3.45
        DII74,38,4977.61 %5.96
        MF49,15,1585.03 %3.48
        Others3,80,62,44038.92 %-3.78

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Shilpa Medicare Board Meeting/AGM

      • Shilpa Medicare Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        May 23, 2024May 16, 2024Board MeetingAudited Results & Final Dividend
        Mar 15, 2024Feb 12, 2024POM-
        Feb 08, 2024Feb 01, 2024Board MeetingQuarterly Results
        Feb 07, 2024Jan 08, 2024POM-
        Nov 10, 2023Nov 03, 2023Board MeetingQuarterly Results
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final110%1.1Sep 19, 2022May 23, 2022
        Final110%1.1Sep 20, 2021May 31, 2021
        Interim110%1.1Mar 16, 2020Mar 03, 2020
        Final100%1.0Sep 12, 2019May 27, 2019
        Interim70%0.7Mar 01, 2018Feb 19, 2018
      • All TypesEx-DateRecord DateAnnounced onDetails
        SplitsNov 06, 2015Nov 09, 2015Aug 12, 2015Split: Old FV2.0| New FV:1.0
        BonusJul 16, 2013-May 29, 2013Bonus Ratio: 1 share(s) for every 2 shares held
        SplitsSep 28, 2007Oct 08, 2007Apr 26, 2007Split: Old FV10.0| New FV:2.0

      About Shilpa Medicare

      Shilpa Medicare Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 6,440.51 Crore) operating in Pharmaceuticals sector. Shilpa Medicare Ltd. key Products/Revenue Segments include Formulations, Finished Goods, Sale of services, Export Incentives, Power for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • OI

        Omprakash Inani

        Chairman
        VC

        Vishnukant C Bhutada

        Managing Director
        KS

        Kalakota Sharath Reddy

        Whole Time Director
        AB

        Anita Bandyopadhyay

        Independent Woman Director
        Show More
      • Bohara Bhandari Bung & Associates LLP
        Brahmayya & Co.

      FAQs about Shilpa Medicare share

      • 1. What is Shilpa Medicare share price and what are the returns for Shilpa Medicare share?
        Shilpa Medicare share price was Rs 658.60 as on 12 Jul, 2024, 04:04 PM IST. Shilpa Medicare share price was down by 1.43% based on previous share price of Rs 650.55. Shilpa Medicare share price trend:
        • Last 1 Month: Shilpa Medicare share price moved up by 22.47%
        • Last 3 Months: Shilpa Medicare share price moved up by 30.22%
        • Last 12 Months: Shilpa Medicare share price moved up 118.26%
        • Last 3 Years: Shilpa Medicare Share price moved up by 9.26%
      • 2. Which are the key peers to Shilpa Medicare?
        Within Pharmaceuticals sector Shilpa Medicare, Orchid Pharma Ltd., Aarti Pharmalabs Ltd., Blue Jet Healthcare Ltd, Sun Pharma Advanced Research Company Ltd., Aarti Drugs Ltd., FDC Ltd., Hikal Ltd., Marksans Pharma Ltd., Strides Pharma Science Ltd. and Unichem Laboratories Ltd. are usually compared together by investors for analysis.
      • 3. What are the key metrics to analyse Shilpa Medicare Share Price?
        Shilpa Medicare share can be quickly analyzed on following metrics:
        • Stock's PE is 202.29
        • Price to Book Ratio of 3.63
      • 4. What are the returns for Shilpa Medicare share?
        Return Performance of Shilpa Medicare Shares:
        • 1 Week: Shilpa Medicare share price moved down by 0.24%
        • 1 Month: Shilpa Medicare share price moved up by 22.47%
        • 3 Month: Shilpa Medicare share price moved up by 30.22%
        • 6 Month: Shilpa Medicare share price moved up by 99.76%
      • 5. Who are the key owners of Shilpa Medicare stock?
          • Promoter holding has not changed in last 9 months and holds 50.01 stake as on 31 Mar 2024
          • Domestic Institutional Investors holding has gone up from 0.37 (30 Jun 2023) to 1.65 (31 Mar 2024)
          • Foreign Institutional Investors holding have gone down from 10.26 (30 Jun 2023) to 5.63 (31 Mar 2024)
          • Other investor holding has gone up from 39.36 (30 Jun 2023) to 42.71 (31 Mar 2024)
      • 6. What is the CAGR of Shilpa Medicare?
        The CAGR of Shilpa Medicare is 6.32.
      • 7. What's the market capitalization of Shilpa Medicare?
        Market Capitalization of Shilpa Medicare stock is Rs 6,440.51 Cr.
      • 8. Who is the chairman of Shilpa Medicare?
        Omprakash Inani is the Chairman of Shilpa Medicare
      • 9. What is 52 week high/low of Shilpa Medicare share price?
        In last 52 weeks Shilpa Medicare share had a high price of Rs 685.00 and low price of Rs 295.05
      • 10. What dividend is Shilpa Medicare giving?
        An equity Final dividend of Rs 1.1 per share was declared by Shilpa Medicare Ltd. on 23 May 2022. So, company has declared a dividend of 110% on face value of Rs 1 per share. The ex dividend date was 19 Sep 2022.
      • 11. What are the Shilpa Medicare quarterly results?
        Total Revenue and Earning for Shilpa Medicare for the year ending 2024-03-31 was Rs 1159.77 Cr and Rs 31.87 Cr on Consolidated basis. Last Quarter 2024-03-31, Shilpa Medicare reported an income of Rs 294.19 Cr and profit of Rs 24.50 Cr.
      • 12. What is the PE & PB ratio of Shilpa Medicare?
        The PE ratio of Shilpa Medicare stands at 205.23, while the PB ratio is 3.22.

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times